Conference Proceedings

ADDITION OF NEPROLYSIN INHIBITOR, LBQ-657 TO ANGIOTENSIN RECEPTOR BLOCKER, VALSARTAN PROVIDES SUPERIOR ANTI-FIBROTIC AND ANTI-HYPERTROPHIC EFFECTS IN VITRO

Bing H Wang, Thomas von Lueder, Li Huang, Andrew Kompa, Randy Webb, Pierre Jordaan, Henry Krum

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | ELSEVIER SCIENCE INC | Published : 2012

DOI: 10.1016/S0735-1097(12)60904-8

University of Melbourne Researchers

Keywords

5.1 Pharmaceuticals
3214 Pharmacology and Pharmaceutical Sciences
Life Sciences & Biomedicine
32 Biomedical and Clinical Sciences
Science & Technology
Cardiovascular System & Cardiology
Cardiac & Cardiovascular Systems